Formulation factors affecting acceptability of oral medicines in children

Fang Liu1, Sejal Ranmal2, Hannah K Batchelor3

  • 1Department of Pharmacy, School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UK.

Insights

Medicines

Area of Science:

  • Pharmaceutical Sciences
  • Paediatric Medicine
  • Drug Formulation

Background:

  • Medicinal product acceptability in children and caregivers is crucial for treatment safety and efficacy.
  • Regulatory bodies require demonstration of paediatric formulation acceptability during product development.
  • Current scientific evidence on age-appropriateness and acceptability of different dosage forms is fragmented.

Purpose of the Study:

  • To highlight formulation factors influencing the acceptability of oral medicines in children.
  • To identify knowledge gaps in paediatric formulation development.
  • To explore the utility of adult study findings for paediatric drug development.

Main Methods:

  • Review of scientific literature on medicine acceptability in children.
  • Analysis of formulation factors impacting oral medicine acceptance.
  • Discussion of findings from adult population studies relevant to paediatrics.

Main Results:

  • Formulation characteristics significantly impact the acceptability of oral medicines for paediatric patients.
  • Specific formulation factors require further investigation for diverse paediatric populations.
  • Adult data can offer preliminary insights for paediatric formulation strategies.

Conclusions:

  • Understanding formulation factors is key to improving paediatric medicine acceptability.
  • Further research is needed to address knowledge gaps in paediatric drug formulation.
  • A strategic approach integrating existing knowledge and new research is essential for effective paediatric formulation development.

Related Concept Videos

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules01:18

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules

Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
405
Oral Drug Delivery Systems: Introduction01:23

Oral Drug Delivery Systems: Introduction

Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
243
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
829
Factors Influencing Drug Absorption: Pharmaceutical Parameters01:28

Factors Influencing Drug Absorption: Pharmaceutical Parameters

Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
780
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
223
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
868